Herbas VPB

Print
EN | LT
LT - N-4-fenilchinazolin-4-amino dariniai ir giminingi junginiai kaip ERBB I tipo receptoriaus tirozinkinazės slopikliai, skirti hiperproliferacinių ligų gydymui
EN - N4-PHENYL-QUINAZOLINE-4 -AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES

Legal status

Patent in force

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 413/14 (2006.01)
C07D 417/14 (2006.01)
C07D 401/14 (2006.01)
C07D 403/12 (2006.01)
C07D 403/14 (2006.01)
C07D 413/12 (2006.01)
C07D 417/12 (2006.01)
C07D 471/04 (2006.01)
C07D 495/04 (2006.01)
A61K 31/517 (2006.01)
A61P 35/00 (2006.01)
European patent
(11) Number of the document 1971601
(13) Kind of document T
(96) European patent application number 06837728.2
Date of filing the European patent application 2006-11-15
(97) Date of publication of the European application 2008-09-24
(45) Date of publication and mention of the grant of the patent 2009-10-21
(46) Date of publication of the claims translation 2010-03-25
PCT application
(86) Number PCT/US2006/044431
Date 2006-11-15
PCT application publication
(87) Number WO 2007/059257
Date 2007-05-24
Priority applications
(30) Number Date Country code
736289 P 2005-11-15 US
817019 P 2006-06-28 US
Inventors
(72)
LYSSIKATOS, Joseph, P., US
MARMSATER, Fredrik, P., US
ZHAO, Qian, US
GRESCHUK, Julie, Marie, US
Grantee
(73) Array Biopharma Inc., 3200 Walnut Street, Boulder, CO 80301, US
Attorney or representative
(74) Marius JAKULIS - JASON, AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius, LT
Title
(54) N-4-fenilchinazolin-4-amino dariniai ir giminingi junginiai kaip ERBB I tipo receptoriaus tirozinkinazės slopikliai, skirti hiperproliferacinių ligų gydymui
  N4-PHENYL-QUINAZOLINE-4 -AMINE DERIVATIVES AND RELATED COMPOUNDS AS ERBB TYPE I RECEPTOR TYROSINE KINASE INHIBITORS FOR THE TREATMENT OF HYPERPROLIFERATIVE DISEASES
Last renewal fee
Payment date Validity (years) Amount
2025-10-14 20 347.00 EUR